Literature DB >> 23542345

Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice.

Ivan Quétier1, Nicolas Brezillon, Marion Duriez, Hélène Massinet, Eric Giang, James Ahodantin, Céline Lamant, Marie-Noëlle Brunelle, Patrick Soussan, Dina Kremsdorf.   

Abstract

BACKGROUND & AIMS: Conflicting results have been reported regarding the impact of hepatitis B virus X protein (HBx) expression on liver regeneration triggered by partial hepatectomy (PH). In the present report we investigated the mechanisms by which HBx protein alters hepatocyte proliferation after PH.
METHODS: PH was performed on a transgenic mouse model in which HBx expression is under the control of viral regulatory elements and liver regeneration was monitored. LPS, IL-6 neutralizing antibody, and SB203580 were injected after PH to evaluate IL-6 participation during liver regeneration.
RESULTS: Cell cycle progression of hepatocytes was delayed in HBx transgenic mice compared to WT animals. Moreover, HBx induced higher secretion of IL-6 soon after PH. Upregulation of IL-6 was associated with an elevation of STAT3 phosphorylation, SOCS3 transcript accumulation and a decrease in ERK1/2 phosphorylation in the livers of HBx transgenic mice. The involvement of IL-6 overexpression in cell cycle deregulation was confirmed by the inhibition of liver regeneration in control mice after the upregulation of IL-6 expression using LPS. In addition, IL-6 neutralization with antibodies was able to restore liver regeneration in HBx mice. Finally, the direct role of p38 in IL-6 secretion after PH was demonstrated using SB203580, a pharmacological inhibitor.
CONCLUSIONS: HBx is able to induce delayed hepatocyte proliferation after PH, and HBx-induced IL-6 overexpression is involved in delayed liver regeneration. By modulating IL-6 expression during liver proliferation induced by stimulation of the cellular microenvironment, HBx may participate in cell cycle deregulation and progression of liver disease.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HBV; HBx; HCC; PH; hepatitis B virus; hepatitis B virus X protein; hepatocellular carcinoma; partial hepatectomy

Mesh:

Substances:

Year:  2013        PMID: 23542345     DOI: 10.1016/j.jhep.2013.03.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.

Authors:  James Ahodantin; Myriam Bou-Nader; Corinne Cordier; Jérôme Mégret; Patrick Soussan; Chantal Desdouets; Dina Kremsdorf
Journal:  Oncogene       Date:  2018-12-11       Impact factor: 9.867

Review 2.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

3.  Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor.

Authors:  Sebastian Robert Barthel; Regina Medvedev; Thekla Heinrich; Sarah Manon Büchner; Nadja Kettern; Eberhard Hildt
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

Review 4.  Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma.

Authors:  Laura Amicone; Alessandra Marchetti
Journal:  Transl Gastroenterol Hepatol       Date:  2018-05-02

Review 5.  Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma.

Authors:  Yinli Yang; Bingqing Zheng; Qiuju Han; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

6.  Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Cheng-Yun Dou; Yu-Chen Fan; Chuang-Jie Cao; Yang Yang; Kai Wang
Journal:  Dig Dis Sci       Date:  2015-12-10       Impact factor: 3.199

7.  Interleukin-6 is required for cell cycle arrest and activation of DNA repair enzymes after partial hepatectomy in mice.

Authors:  Shingo Tachibana; Xiuying Zhang; Kazushige Ito; Yoshihiro Ota; Andrew M Cameron; George Melville Williams; Zhaoli Sun
Journal:  Cell Biosci       Date:  2014-02-03       Impact factor: 7.133

8.  Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.

Authors:  Lin Quan Tang; Dong Peng Hu; Qiu Yan Chen; Lu Zhang; Xiao Ping Lai; Yun He; Yun-Xiu-Xiu Xu; Shi-Hua Wen; Yu-Tuan Peng; Wen-Hui Chen; Shan-Shan Guo; Li-Ting Liu; Chao-Nan Qian; Xiang Guo; Mu-Sheng Zeng; Hai-Qiang Mai
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  Hepatitis B Virus X Protein Upregulates hELG1/ ATAD5 Expression through E2F1 in Hepatocellular Carcinoma.

Authors:  Alip Ghosh; Suchandrima Ghosh; Debanjali Dasgupta; Amit Ghosh; Somenath Datta; Nilabja Sikdar; Simanti Datta; Abhijit Chowdhury; Soma Banerjee
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

10.  Phosphatidylcholine alteration identified using MALDI imaging MS in HBV-infected mouse livers and virus-mediated regeneration defects.

Authors:  Eun-Sook Park; Jeong Hwa Lee; Ji Hye Hong; Yong Kwang Park; Joon Won Lee; Won-Jae Lee; Jae Won Lee; Kwang Pyo Kim; Kyun-Hwan Kim
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.